Percutaneous closure of the left atrial appendage with Watchman device: An option for patients with atrial fibrilation and high risk of bleeding with anticoagulation
Atrial fibrillation is the most common arrhythmia found in clinical practice, with a population prevalence of 1% to 2%. Anticoagulation remains a fundamental part of treatment for the prevention of cerebrovascular events (stroke), but it is contraindicated in approximately 20% of patients. We report...
Main Authors: | Sénior, Juan, Borja, Henry, Fernández, Andrés, Rodríguez, Arturo, Aldana, Víctor |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Universidad de Antioquia
2015-07-01
|
Series: | Iatreia |
Subjects: | |
Online Access: | http://aprendeenlinea.udea.edu.co/revistas/index.php/iatreia/article/view/22705 |
Similar Items
-
Safety and efficacy of transcatheter left atrial appendage closure using the Watchman device in Egyptian patients with nonvalvular atrial fibrillation
by: Hazem Khamis, et al.
Published: (2016-03-01) -
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
by: Alipour A, et al.
Published: (2017-03-01) -
Surgical retrieval of a left atrial appendage closure device (Watchman TM) following embolization into the mitral valve
by: Kevin P Birmingham, et al.
Published: (2019-01-01) -
Markers of coagulation and fibrinolysis do not detect or predict the presence of left atrial appendage thrombus in patients with atrial fibrillation
by: Ersin Doğanözü, et al.
Published: (2020-03-01) -
Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience
by: Karen P. Phillips, MBBS, et al.
Published: (2016-04-01)